← Back
$AQST All transactions

Aquestive Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$311K

Shares

62,180

Price

$5

Filed

Sep 8

Insider

Name

Jung Cassie

Title

Chief Operating Officer

CIK

0001960154

Roles

Officer

Transaction Details

Transaction Date

2025-09-04

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

283,346

Footnotes

This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4. | This option was granted on August 9, 2019 and is fully vested. | This option was granted on August 5, 2022 and is fully vested.

Filing Info

Accession No.

0001214659-25-013493

Form Type

4

Issuer CIK

0001398733

Jung Cassie's History

Date Ticker Type Value
2026-03-10 AQST $191K
2026-03-09 AQST A $0
2026-03-09 AQST A $0
2025-10-15 AQST M $78K
2025-10-15 AQST $474K
2025-10-15 AQST M $0
2025-09-04 AQST M $79K
2025-09-04 AQST M $18K
2025-09-04 AQST $311K
2025-09-04 AQST M $0

Other Insiders at AQST (90d)

Insider Bought Sold Last
TOTH A ERNEST JR
Chief Financial Officer
$243K 2026-03-10
TOTH A ERNEST JR
SVP, Chief Financial Officer
2025-03-07
Boyd Peter E.
Chief People Officer
$124K 2026-03-10
Barber Daniel
President and CEO
$754K 2026-03-10
BRAENDER LORI J
Chief Legal Officer
$167K 2026-03-10
BRAENDER LORI J
Corporate Secretary
2025-03-07
Jung Cassie
Chief Operating Officer
$191K 2026-03-10
Korczynski Sherry
Chief Commercial Officer
$66K 2026-03-10
Cioffi Melina
SVP, Regulatory Affairs
$106K 2026-03-10
Davis Matthew W.
Chief Development Officer
2026-03-09
Greenhawt Matthew J.
Chief Medical Officer
2026-03-09